<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Vascular risk factors increase the risk of <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Increased concentrations of circulating <z:chebi fb="0" ids="17230">homocysteine</z:chebi> are associated with vascular risk factors and <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> but the underlying mechanisms are unclear </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="0" ids="17230">Homocysteine</z:chebi> inhibits the hydrolysis of S-adenosylhomocysteine leading to a decrease in the intracellular <z:chebi fb="3" ids="16335">adenosine</z:chebi> concentration </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="3" ids="16335">Adenosine</z:chebi> is an endogenous protective molecule against atherosclerotic and vaso-occlusive disorders that contribute to the pathology of <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>In this study the concentrations of <z:chebi fb="0" ids="17230">homocysteine</z:chebi> and <z:chebi fb="3" ids="16335">adenosine</z:chebi> were determined in the plasma of 25 patients with <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> and 25 control subjects </plain></SENT>
<SENT sid="5" pm="."><plain>There was a significant increase in the plasma concentration of <z:chebi fb="0" ids="17230">homocysteine</z:chebi> (p &lt; 0.0001) and a significant decrease in the plasma concentration of <z:chebi fb="3" ids="16335">adenosine</z:chebi> (p &lt; 0.001) </plain></SENT>
<SENT sid="6" pm="."><plain>In the combined Alzheimer and control groups a significant negative correlation was found between the plasma concentrations of <z:chebi fb="0" ids="17230">homocysteine</z:chebi> and <z:chebi fb="3" ids="16335">adenosine</z:chebi> (r = -0.769, p &lt; 0.0001) </plain></SENT>
<SENT sid="7" pm="."><plain>There was also a significant negative correlation between the plasma concentrations of <z:chebi fb="0" ids="17230">homocysteine</z:chebi> and <z:chebi fb="3" ids="16335">adenosine</z:chebi> in the Alzheimer group (r =-0.773, p &lt; 0.0001) </plain></SENT>
<SENT sid="8" pm="."><plain>The decrease in <z:chebi fb="3" ids="16335">adenosine</z:chebi> formation may play a role in the vascular pathology of <z:chebi fb="0" ids="17230">homocysteine</z:chebi> in <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> </plain></SENT>
</text></document>